COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 8, Pages 1594
Publisher
MDPI AG
Online
2021-08-12
DOI
10.3390/v13081594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 convalescent plasma composition and immunological effects in severe patients
- (2021) Yeny Acosta-Ampudia et al. JOURNAL OF AUTOIMMUNITY
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
- (2021) Michael J. Joyner et al. NEW ENGLAND JOURNAL OF MEDICINE
- α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
- (2021) Chengliang Yang et al. Lancet Respiratory Medicine
- Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
- (2021) Matthew K Hensley et al. CLINICAL INFECTIOUS DISEASES
- Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19
- (2021) Christophe Guervilly et al. Blood Advances
- Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment
- (2021) Daniele Focosi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
- (2021) William R. Morgenlander et al. JOURNAL OF CLINICAL INVESTIGATION
- Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19
- (2021) Matthew Kheir et al. PLoS One
- COVID‐19 convalescent plasma therapy: hit fast, hit hard!
- (2021) Daniele Focosi et al. VOX SANGUINIS
- Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices
- (2021) Gopal K. Patidar et al. VOX SANGUINIS
- Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
- (2021) Harini Natarajan et al. mBio
- High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
- (2021) Uri Greenbaum et al. Frontiers in Immunology
- Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score
- (2021) Sanjana R. Sen et al. mSphere
- The Three Pillars of COVID-19 Convalescent Plasma Therapy
- (2021) Massimo Franchini et al. Life-Basel
- Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin
- (2021) Daniele Focosi et al. Life-Basel
- Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent
- (2021) Olivier Vollmer et al. AUTOIMMUNITY REVIEWS
- Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets
- (2021) Alexander P Bye et al. BLOOD
- The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19
- (2021) Elke Zani-Ruttenstock et al. EUROPEAN JOURNAL OF PEDIATRIC SURGERY
- Treatment of COVID-19 Patients with Convalescent Plasma
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia
- (2020) Carmine Gazzaruso et al. CLINICAL RHEUMATOLOGY
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Is Albumin Predictor of Mortality in COVID-19?
- (2020) Francesco Violi et al. ANTIOXIDANTS & REDOX SIGNALING
- Anti‐A isohaemagglutinin titres and SARS‐CoV‐2 neutralization: implications for children and convalescent plasma selection
- (2020) Daniele Focosi BRITISH JOURNAL OF HAEMATOLOGY
- Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial
- (2020) Cesare Perotti et al. HAEMATOLOGICA
- Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
- (2020) Michael J. Joyner et al. MAYO CLINIC PROCEEDINGS
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Infusion of Convalescent Plasma is Associated with Clinical Improvement in Critically Ill Patients with COVID-19: A Pilot Study
- (2020) Juan C. Olivares-Gazca et al. Revista de Investigacion Clinica-Clinical and Translational Investigation
- Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin
- (2020) Carmine Gazzaruso et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID‐19 and immunological dysregulation: can autoantibodies be useful?
- (2020) Simona Pascolini et al. CTS-Clinical and Translational Science
- Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19
- (2020) Paul P. Dobesh et al. PHARMACOTHERAPY
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
- (2020) Maria Orietta Borghi et al. Frontiers in Immunology
- SARS‐CoV‐2 infection as a trigger of autoimmune response
- (2020) Maria C. Sacchi et al. CTS-Clinical and Translational Science
- Novel coronavirus disease (COVID‐19) update on epidemiology, pathogenicity, clinical course and treatments
- (2020) Marko Boban INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Covid-19 and blood groups: ABO antibody levels may also matter
- (2020) Marie Deleers et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report
- (2020) Francesco Violi et al. THROMBOSIS AND HAEMOSTASIS
- Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
- (2020) Jeffrey E. Gold et al. mBio
- Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells
- (2020) Youjeong Kwon et al. Stem Cell Research & Therapy
- A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China
- (2020) Shuang Huang et al. MEDICAL SCIENCE MONITOR
- Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma
- (2020) Tania S Bonny et al. Open Forum Infectious Diseases
- Extracellular vesicles containing ACE2 efficiently prevent infection by SARS‐CoV‐2 Spike protein‐containing virus
- (2020) Federico Cocozza et al. Journal of Extracellular Vesicles
- Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow
- (2016) O. Garraud et al. TRANSFUSION CLINIQUE ET BIOLOGIQUE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started